In the news

$2 million SBIR grant fast-tracks cancer drug platform technology, which aims to better treat relapse

A $1,999,998 SBIR Phase I/II grant from the National Cancer Institute to KinaRx LLC, a Purdue University-affiliated startup, will help fast-track to human trials a novel platform aimed at treating relapse for AML and other diseases.

February 26, 2020

Stretchable, wearable coils may make MRI, other medical tests easier on patients

Anyone who has had a mammogram or an MRI knows how uncomfortable and awkward the tests can be. Now, Purdue University researchers have taken technology used in the defense and aerospace industries to create a novel way of doing some medical imaging.

February 13, 2020

Pancreatic cancer ‘time machine’ exposes plot twist in cell growth and invasion

Invasive cancer sprouts from an artificial pancreatic duct engineered by Purdue University researchers. The cell bodies are stained magenta and the nuclei are stained blue.

February 10, 2020

Study identifies interaction that promotes cancerous state in cells

Lsd1 together with other enzymes drives enhancer repression during stem cells differentiation. But in some cancer cells, a protein called OCT4 inhibits Lsd1 activity, leaving enhancers primed and vulnerable to signal of activation

February 7, 2020

Novel techniques for mining patented gene therapies offer promising treatment options for cancers, other diseases

A team of scientists from Purdue University and institutions around the world have come together to better understand the growing number of worldwide patented innovations available for gene therapy treatment.

February 6, 2020

Purdue-discovered ‘fluorescent markers’ to illuminate cancer, improve outcomes, receives FDA fast track as Phase 3 clinical trials begin

Intraoperative molecular imaging used to illuminate and target non-small-cell lung cancer shows improved outcomes for 26% of patients in multi-institutional Phase 2 clinical trial.

January 24, 2020

Dr. Andrew Mesecar, Deputy Director of the Purdue Center for Cancer Research, is Working with Global Scientists in the Race Against the Coronavirus

The genome was posted on a Friday night on an open-access repository for genetic information. By Saturday morning, Andrew Mesecar, a professor of cancer structural biology at Purdue University, had redirected his laboratory to start analyzing the DNA sequence.

January 16, 2020

Pair of Purdue students continuing legacy of Tyler Trent in supporting cancer research, innovations

A pair of Purdue University students who have personal connections to cancer will help carry on the legacy of Tyler Trent, a Purdue graduate and superfan who died from a rare type of bone cancer.

January 14, 2020

A technology devised to help reduce injection pain, swelling from some best-selling drugs

Purdue University researchers have developed technology to help drug manufacturers create new formulations and injection devices of medications to reduce the pain and discomfort.

December 19, 2019

This ‘lemon’ could help machine learning create better drugs

Purdue University drug discovery researchers have created a new framework for mining data for training machine learning models.